TARGETED intra-operative radiotherapy (TARGIT©) may one day become the standard treatment for post-surgery breast cancer radiotherapy according to the results of an international clinical trial involving WA researchers.

HEALTHY WA women are being asked to take part in an international breast cancer study to see if the drug Anastrozole can prevent the disease in women most at risk.

LOCAL researchers and Canadian scientists have collaborated to investigate the possibility of a link between shift work and breast cancer.

THE mapping of the human epigenome, Time Magazine’s second top scientific discovery of 2009, was achieved with the invaluable research of University of Western Australia (UWA) scientists and may now hold the key for potential cancer therapies.

A RESEARCH team at Royal Perth Hospital’s Cell and Tissue Therapies (CTTWA) facility have designed a life-saving stem cell therapy, already responsible for bringing a Perth teenager back from the brink of death.

AS a teenager, Lane Martino was handed a “death sentence” after developing acute graft-versus-host disease, but in an amazing twist, a team of doctors saved his life with cell therapy techniques developed here in Perth.

WESTERN Australian communities will be exposed to dangerous levels of radiation resulting in higher risks of cancer and hereditary disease, if the push towards opening new uranium mines and a domestic nuclear fuel program is successful, according to Dr Irene Kirzcenow.

WHEN Dr Swaminathan Iyer is working, it’s hard to see what he’s doing – because most of his research focuses on things that can’t be seen with the human eye.

PATIENTS undergoing computed radiography imaging will be protected from excessive levels of radiation in medical exams, thanks to a groundbreaking monitoring program from researchers at Curtin University.

BREAST cancer survivors will soon have a way of keeping in touch with fellow patients and their families from the comfort of their own homes, thanks to an online community being developed in 2010 by Edith Cowan University and the WA Breast Cancer Foundation.

AN innovative breast cancer imaging system which claims to eliminate patient discomfort and provide greater accuracy compared to traditional methods is being trialed at Edith Cowan University.

BIOPHARMICA Ltd (BPH) is sailing toward pre-clinical testing of a new class of anti-cancer drugs, with Dr Robin Scaife at the helm.

BPH Corporate Limited [ASX: BPH]

BPH Corporare Limited (BPH) manages a strong portfolio of biomedical technologies emerging from research by leading Universities, Medical Institutes and Hospitals across Australia.  The company provides early stage funding, project management and commercialisation strategies for proof of concept for a direct collaboration, a spin out company or to secure a license, whilst the institutional partner provides infrastructure and the core scientific expertise.

Please click here to preview our company overview.

Here are some recent news items about our research:

BioPharmica confirms 100% ownership of new anti-cancer agents

New Anti-Mitotic Drug Development for Pre-Clinical Testing

US patent granted for HLS5

Contact details:

Bianca AfricanoBPH Corporate Limited ABN 41 095 912 00214 View Street, North Perth  Western Australia  6006D:  +61 8 6467 9504   T: +61 8 9328 8366   F: +61 8 9328 8733   M: +61 403 123 160bianca@bphcorporate.com.au  www.bphcorporate.com.au

URANIUM mining could present WA communities with a variety of health defects, from leukemia to congenital defects, according to a health expert at a recent forum.

PANCREATIC cancer has a tough new opponent, a molecule described as a ‘Trojan horse’ and developed by a Western Australian Institute for Medical Research (WAIMR) team.

A REPORT co-authored by a Perth professor reveals for the first time a link between bowel cancer and a specific, yet common, genetic abnormality.

RESEARCHERS from the University of WA have identified a genetic variation in the MTHFR gene that increases the risk of developing tumours on one side of the large bowel.

COURAGEOUS researchers are teaming up to investigate a new treatment for children with leukaemia, based on a novel approach by a Perth scientist.

MORE than 5000 WA marine species, some with cancer-killing and other medical and industrial potentials, will be housed in a newly-opened facility in Perth.